KLRK1 and myalgic encephalomeyelitis/chronic fatigue syndrome: At 6 months, CD56brightCD16dim NK cells expressing NKG2D were significantly reduced in severe CFS/ME compared to moderate CFS/ME patients (p = 0.014) (Fig. 5a).